glp-1 lawsuit Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs A nurse lost her eyesight
Description
Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes
These adaptations position irisin as a promising therapeutic target for preventing metabolic disorders and optimizing exercise protocols
Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment
Despite effectiveness, side effects like nausea and diarrhea are common, and most Americans say they dont plan to take them.
Researchers are exploring whether semaglutide drugs like Ozempic and Wegovy could help prevent cognitive decline
